Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6GILEAD SCIENCES INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 11596614

Drug Substance Claim :

Drug Product Claim :

Application Number : 217899

Patent Use Code : U-1854

Delist Requested :

Patent Use Description : TREATMENT OF PRIMARY B...

Patent Expiration Date : 2035-03-19

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 11406611

Drug Substance Claim :

Drug Product Claim :

Application Number : 217899

Patent Use Code : U-1854

Delist Requested :

Patent Use Description : TREATMENT OF PRIMARY B...

Patent Expiration Date : 2035-03-19

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 10272058

Drug Substance Claim :

Drug Product Claim :

Application Number : 217899

Patent Use Code : U-1854

Delist Requested :

Patent Use Description : TREATMENT OF PRIMARY B...

Patent Expiration Date : 2035-03-19

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 9486428

Drug Substance Claim :

Drug Product Claim :

Application Number : 217899

Patent Use Code : U-1854

Delist Requested :

Patent Use Description : TREATMENT OF PRIMARY B...

Patent Expiration Date : 2035-03-19

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 7709682

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 217899

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-09-13

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SELADELPAR LYSINE

US Patent Number : 7301050

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 217899

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-08-02

blank